Company: MGLD
Filing Date: 2025-01-27
Form Type: 424B5
Source: 0001493152-25-003788
Chunk: 16

Company: Marygold Companies, Inc.
Filing Date: 2025-01-27
Form: 424B5
Chunk 16
---
 have been approximately $26,084,500, or approximately $0.62 per share of common stock. This represents an immediate increase in as adjusted net tangible book value of $0.02 per share to our existing stockholders and an immediate dilution in net tangible book value of $0.48 per share to investors participating in this offering.

Dilution per share to new investors is determined by subtracting as adjusted net tangible book value per share after this offering from the public offering price per share paid by new investors. The following table illustrates this per share dilution to new investors:

| Public offering price per share                                                    |     |   |      |     | $ | 1.10 |
| Historical net tangible book value per share as of September 30, 2024              |     | $ | 0.60 |     |   |      |
| Increase in net tangible book value per share attributable to this offering        |     |   | 0.02 |     |   |      |
| As adjusted net tangible book value per share after giving effect to this offering |     |   |      |     |   | 0.62 |
| Dilution in net tangible book value per share to investors in this offering        |     |   |      |     | $ | 0.48 |

The foregoing table and discussion above are based on 40,326,035 shares of our common stock outstanding as of September 30, 2024, and excludes:

| ● | 640,881                                                                                        
 shares of our common stock issuable upon exercise of stock options outstanding as of September 
 30, 2024                                                                                       |
| ● | 987,200                                                                                        
 shares issuable upon conversion of outstanding shares of our Series B Preferred Stock,         |
| ● | 3,425,644                                                                                      
 shares reserved for future issuance pursuant to our 2021 Omnibus Equity Incentive              
 Plan                                                                                           |

To the extent that any options are exercised, new options are granted under our 2021 Omnibus Equity Incentive Plan or we otherwise issue additional shares of common stock or securities convertible into or exercisable for our shares of common stock in the future (including shares issued in connection with one or more acquisitions we may make), there may be further dilution to new investors. To the extent we raise additional capital through sales of our shares of common stock or convertible securities, there may be further dilution.

In addition, we may choose to raise additional capital due to market conditions